Delivery Order SPE2DR25D1021-SPE2DR26FNL4M
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $84,982.81 to AmerisourceBergen Drug Corp for the supply of Jadenu 360 mg tablets (30-count units) on October 15, 2025, with an ultimate completion date of October 16, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $12,031.54 delivery order to AmerisourceBergen Drug Corp for Jadenu 360 mg tablets (30-count units) on October 24, 2025, with an ultimate completion date of October 27, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- AmerisourceBergen Drug Corp received a $37,524.35 delivery order from the Defense Logistics Agency (DLA) on July 17, 2025, for the supply of Jadenu 360 mg tablets (30-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jadenu is an iron chelation therapy medication used to treat chronic iron overload, a condition common...
- The Defense Logistics Agency awarded a $40,176.29 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of JADENU 360 mg tablets (30-count packages). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $21,735.08 to AmerisourceBergen Drug Corp for JADENU 360 mg tablets (30-count) on October 30, 2025, with completion scheduled for October 31, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate headquarters location in Conshohocken, Pennsylvania. As a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $25,015.31 to AmerisourceBergen Drug Corp for the supply of JADENU 360 mg tablets (30-count) under a firm fixed-price contract type. The award was made on September 10, 2025, with an ultimate completion date of September 11, 2025, and is not designated as a set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,490.00 by the Defense Logistics Agency's Medical Supply Chain for the supply of Jadenu 360 mg tablets (30-count units). The award, issued on June 2, 2025, with a completion date of June 3, 2025, represents a firm fixed-price contract with no set-aside designation, indicating competitive award. The point of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,062.11 to AmerisourceBergen Drug Corp for the supply of JADENU 360 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $28,728.06, is for the supply of JADENU 360 MG TABLET 30S, a specialty pharmaceutical product. The award has an ultimate completion date of October 16, 2024 and was made on October 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...
- The Defense Logistics Agency Troop Support Medical awarded a $22,779 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562164284 Jadenu 360 mg tablets. The order is for 30 tablets to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 14, 2023. No additional details were provided regarding the original solicitation or whether this order is associated with any particular contracting vehicle. The award was made without any set aside...
- SPE2DR25D1021Indefinite Delivery Contract
- SPE2DR25D1021-SPE2DR26FNL4MDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Jadenu 360 mg tablets (30-count units) with a ceiling value of $20,184.03. This firm fixed-price delivery order, which is scheduled for completion by October 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The award was made through open competition with no set-aside designation, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health System. As a prime vendor under the DLA Troop Support Medical program, the company supplies an extensive portfolio of pharmaceutical products and medical supplies to support military healthcare operations globally. This particular delivery order for Jadenu—an iron chelation therapy medication—reflects the company's ongoing role in fulfilling specialized pharmaceutical needs for federal healthcare systems supporting the Defense Department and other government medical programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.2k | 10/28/25 |